← SynDRA
ISOQUERCETIN
SynDRA canonical compound SYN0008084 — structure-anchored drug synonym record
| Clinical phase | Phase 2/Phase 3 |
|---|
| Primary target(s) | AKR1B1 |
|---|
| Mechanism of action | Aldose reductase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- Aldose reductase inhibitor
- antioxidant
- AKR1B1 INHIBITOR
- SLC33A1 INHIBITOR
Cross-references
Synonyms
- Isoquercitrin
- 3-glucosylquercetin
- Contigoside b
- Glucosyl-3-quercetin
- Hirsutrin
- Isoquercetin, (-)-
- Isoquercitroside
- Isotrifoliin
- Isotrifolin
- Quercetin 3-d-glucoside
- Quercetin 3-o-glucopyranoside
- Quercetin-3-o-glucoside
- Quercetin 3.beta.-glucoside
- Quercetin glucoside
- Quercetin-3-glucose
- Quercetol 3-monoglucoside
- Ronacare isoquercetin
- FEMA NO. 4225
- NSC-115918
- NSC-407304
- CONTIGOSIDE B
- 3-Glucosylquercetin
- Glucosyl 3-quercetin
- quercetin-3-glucoside
- Quercetol 3-glucoside
- Quercetin-3-O-glucopyranoside
- Quercetin 3-D-glucoside
- Quercetin 3-monoglucoside
- Quercetin 3-beta-glucoside
- quercetin-3-O-glucoside
- Quercetin 3-beta-O-glucoside
- UNII-6HN2PC637T
- NSC 115918
- BRN 0100989
- CHEMBL250450
- 6HN2PC637T
- CHEBI:68352
- quercetin 3-O-beta-D-glucopyran
Look up ISOQUERCETIN in the interactive SynDRA portal →